Xience Sierra TM Everolimus Eluting Coronary Stent System — Class II medical device recall Z-2370-2020
Terminated recall by Abbott Vascular, reported 2020-06-24, distributed nationwide. Incorrect expiration date
| Recall number | Z-2370-2020 |
|---|---|
| Product type | Medical device |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Abbott Vascular, Temecula, CA, United States |
| Recall initiated | 2020-03-25 |
| Classified | 2020-06-15 |
| Reported by FDA | 2020-06-24 |
| Terminated | 2021-07-12 |
| Distributed | Nationwide (US) |
| Quantity | 13 units |
| Reason classes | labeling |
| UPC / GTIN / UDI-DI | 08717648227455 |
| Lot numbers | 903224A |
Product
Xience Sierra TM Everolimus Eluting Coronary Stent System, RX 3.5mm x 33mmStrength: 100 ¿g/cm¿, Nominal Everolimus Content: 209 ¿g; Lot number 903224A,
Reason for recall
Incorrect expiration date
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/Z-2370-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.